{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"2.210","floor":"1.560"},"ipodate":{"start":"2014-12-16 00:00:00","end":"2014-12-19 00:00:00"},"minimumcapital":"3348.42","subscribed":"49.30","marketcap":"9.18億","H_marketcap":"--","pe":"16.97","codesrate":"60.06","link":"https://staticpdf.iqdii.com/stockdata/notice/Prospectus/01035/LTN20141216014_C.pdf","ipopricing":"1.750","resultdate":"2014-12-29 00:00:00","enddate":"2014-12-19 00:00:00","listeddate":"2014-12-30 00:00:00","issuenumber":"13116.60萬","issuenumberhK":"1311.90萬","issuenumberother":"11804.70萬","grayprice":"1.81","sponsors":"海通國際資本有限公司","raisemoney":"18510.00萬","use":"1、約30.50%或61.5百萬港元，將用于深化產品及服務組合。我們擬于二零一六年應用所得款項凈額于此用途；\n2、約18.60%或37.5百萬港元，將用作拓寬產品及服務組合；\n3、約36.20%或73.0百萬港元，將用作建設與深化及拓寬我們產品及服務組合的上述策略有關的新工廠；\n4、約4.50%或9.1百萬港元，將用作加強信息技術能力；\n5、約7.20%或14.5百萬港元，將用于通過設立新的分公司拓展我們的直銷網絡；\n6、約3.00%或6.1百萬港元，將用作加強網上銷售平臺及培養網上客戶群。\n","shares":1500,"leadagent":"海通國際資本有限公司","bookrunners":"海通國際資本有限公司","coordinator":"海通國際資本有限公司","firstDayOpen":"1.71","IsEiio":0,"Interestdays":10,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"海通國際證券有限公司","code":"E01035","name":"BBI生命科技","fullname":"BBI生命科學有限公司"},"institutioninfo":{"principaloffice":"上海市松江區香閔路698號","registrars":"香港中央證券登記有限公司","registrarstel":"(852) 2862 8628","chairman":"王啟松","secretary":"伍秀薇,胡恒","telephone":"(8621) 800 820 1016","substantialshareholders":"王啟松(57.24%),Grandeur Peak Global Advisors, LLC(9.07%),Matthews International Capital Management, LLC(5.99%)","principalactivities":"集團主要從事用于科學研究的多種生命科學產品的開發、制造及銷售，并提供生命科學相關服務。","website":"http://www.bbi-lifesciences.com"},"managerinfo":[],"investorinfo":[{"institutionname":"Pine River China Master Fund Ltd.","shareholding":"20,616,000.0","percentage":3.9,"ReleaseDate":"2015-06-30 00:00:00","relatedparty":"Pine River Capital Management L.P.","subsidiary":["Pine River China Master Fund Ltd."],"InverstorType":"基金"},{"institutionname":"中國新經濟投資有限公司","shareholding":"10,308,000.0","percentage":2,"ReleaseDate":"2015-06-30 00:00:00","relatedparty":"Quasar Investment Management (Cayman) Limited","subsidiary":["中國新經濟投資有限公司"],"InverstorType":"公司"},{"institutionname":"中國新銳醫藥控股有限公司","shareholding":"10,308,000.0","percentage":2,"ReleaseDate":"2015-06-30 00:00:00","relatedparty":"新銳醫藥國際控股有限公司","subsidiary":["中國新銳醫藥控股有限公司"],"InverstorType":"公司"}],"TotalShareholdingPercentage":7.9},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":512}